GRIN2B and neoplasm: Other groups, on the other hand, found that NR2B promoter methylation exhibits tumor-suppressive activity in human esophageal (Kim et al. 2006) and gastric cancers (Liu et al. 2007), as well as in non-small cell lung carcinoma (Tamura et al. 2011).